CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 169 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,515,000 | -11.3% | 132,571 | +0.6% | 0.15% | -20.7% |
| Q4 2021 | $5,092,000 | +22.0% | 131,771 | +70.5% | 0.18% | +44.9% |
| Q3 2021 | $4,173,000 | +18.8% | 77,285 | -26.4% | 0.13% | +16.5% |
| Q2 2021 | $3,513,000 | +4.2% | 105,056 | -35.8% | 0.11% | +13.5% |
| Q1 2021 | $3,370,000 | +57.6% | 163,615 | +13.5% | 0.10% | -12.7% |
| Q3 2020 | $2,138,000 | -34.2% | 144,200 | -42.3% | 0.11% | -64.9% |
| Q2 2020 | $3,251,000 | – | 250,100 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |